Michael W. Bonney - 18 Mar 2026 Form 3 Insider Report for Autolus Therapeutics plc (AUTL)

Role
Director
Signature
/s/ Michael Bonney
Issuer symbol
AUTL
Transactions as of
18 Mar 2026
Net transactions value
$0
Form type
3
Filing time
18 Mar 2026, 19:55:51 UTC
Previous filing
19 Aug 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
BONNEY MICHAEL W Director C/O AUTOLUS THERAPEUTICS PLC, THE MEDIAWORKS, 191 WOOD LN, WHITE CITY, LONDON, UNITED KINGDOM /s/ Michael Bonney 18 Mar 2026 0001219016

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding AUTL Share Option (right to buy) 18 Mar 2026 American Depositary Shares 120,000 $5.68 Direct F1
holding AUTL Share Option (right to buy) 18 Mar 2026 American Depositary Shares 80,000 $3.48 Direct F2
holding AUTL Share Option (right to buy) 18 Mar 2026 American Depositary Shares 80,000 $2.32 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vested or vests in 36 equal monthly installments commencing on May 1, 2024.
F2 Fully vested and exercisable.
F3 This option vested or vests in twelve equal monthly installments commencing on July 26, 2025.